Literature DB >> 8986758

Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding.

H Wu1, D G Myszka, S W Tendian, C G Brouillette, R W Sweet, I M Chaiken, W A Hendrickson.   

Abstract

The T-cell antigen coreceptor CD4 also serves as the receptor for the envelope glycoprotein gp120 of HIV. Extensive mutational analysis of CD4 has implicated residues from a portion of the extracellular amino-terminal domain (D1) in gp120 binding. However, none of these proteins has been fully characterized biophysically, and thus the precise effects on molecular structure and binding interactions are unknown. In the present study, we produced soluble versions of three mutant CD4 molecules (F43V, G47S, and A55F) and characterized their structural properties, thermostability, and ability to bind gp120. Crystallographic and thermodynamic analysis showed minimal structural alterations in the F43V and G47S mutant proteins, which have solvent-exposed mutant side chains. In contrast, some degree of disorder appears to exist in the folded state of A55F, as a result of mutating a buried side chain. Real time kinetic measurements of the interaction of the mutant proteins with gp120 showed affinity decreases of 5-fold for G47S, 50-fold for A55F, and 200-fold for F43V. Although both rate constants for the binding reaction were affected by these mutations, the loss in affinity was mainly due to a decrease in on rates, with less drastic changes occurring in the off rates. These observations suggest the involvement of conformational adaptation in the CD4-gp120 interaction. Together, the structural and kinetic data confirm that F43V is a critical residue in gp120 recognition site, which may also include main chain interactions at residue Gly-47.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986758      PMCID: PMC26350          DOI: 10.1073/pnas.93.26.15030

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation.

Authors:  C A Janeway
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors.

Authors:  S J Davis; G A Schockmel; C Somoza; D W Buck; D G Healey; E P Rieber; C Reiter; A F Williams
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Comparison of a structural and a functional epitope.

Authors:  B C Cunningham; J A Wells
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

4.  Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains.

Authors:  R L Brady; E J Dodson; G G Dodson; G Lange; S J Davis; A F Williams; A N Barclay
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

5.  Bound water molecules and conformational stabilization help mediate an antigen-antibody association.

Authors:  T N Bhat; G A Bentley; G Boulot; M I Greene; D Tello; W Dall'Acqua; H Souchon; F P Schwarz; R A Mariuzza; R J Poljak
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

6.  Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.

Authors:  D W Brighty; M Rosenberg; I S Chen; M Ivey-Hoyle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

7.  Physical association of CD4 with the T cell receptor.

Authors:  U Dianzani; A Shaw; B K al-Ramadi; R T Kubo; C A Janeway
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

8.  Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices.

Authors:  S E Ryu; A Truneh; R W Sweet; W A Hendrickson
Journal:  Structure       Date:  1994-01-15       Impact factor: 5.006

9.  The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.

Authors:  U Moebius; L K Clayton; S Abraham; S C Harrison; E L Reinherz
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

10.  Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.

Authors:  D A Vignali; J L Strominger
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  24 in total

1.  Energetics of the HIV gp120-CD4 binding reaction.

Authors:  D G Myszka; R W Sweet; P Hensley; M Brigham-Burke; P D Kwong; W A Hendrickson; R Wyatt; J Sodroski; M L Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Kinetic analysis of binding interaction between the subgroup A Rous sarcoma virus glycoprotein SU and its cognate receptor Tva: calcium is not required for ligand binding.

Authors:  Xuemei Yu; Qing-Yin Wang; Ying Guo; Klavs Dolmer; John A T Young; Peter G W Gettins; Lijun Rong
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  High-affinity interaction between IKKbeta and NEMO.

Authors:  Yu-Chih Lo; Upendra Maddineni; Jee Y Chung; Rebecca L Rich; David G Myszka; Hao Wu
Journal:  Biochemistry       Date:  2008-02-12       Impact factor: 3.162

4.  The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4.

Authors:  Ignacio J Juncadella; Renu Garg; Tonya C Bates; Elias R Olivera; Juan Anguita
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

5.  Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer.

Authors:  Qingbo Liu; Priyamvada Acharya; Michael A Dolan; Peng Zhang; Christina Guzzo; Jacky Lu; Alice Kwon; Deepali Gururani; Huiyi Miao; Tatsiana Bylund; Gwo-Yu Chuang; Aliaksandr Druz; Tongqing Zhou; William J Rice; Christoph Wigge; Bridget Carragher; Clinton S Potter; Peter D Kwong; Paolo Lusso
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

6.  Slow, reversible, coupled folding and binding of the spectrin tetramerization domain.

Authors:  S L Shammas; J M Rogers; S A Hill; J Clarke
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

7.  Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies.

Authors:  Ruijiang Song; Craig Pace; Michael S Seaman; Qing Fang; Ming Sun; Chasity D Andrews; Amos Wu; Neal N Padte; David D Ho
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

Review 8.  Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis.

Authors:  Chanakha K Navaratnarajah; Alex R Generous; Iris Yousaf; Roberto Cattaneo
Journal:  J Biol Chem       Date:  2020-01-16       Impact factor: 5.157

9.  Identification of allosteric disulfides from prestress analysis.

Authors:  Beifei Zhou; Ilona B Baldus; Wenjin Li; Scott A Edwards; Frauke Gräter
Journal:  Biophys J       Date:  2014-08-05       Impact factor: 4.033

Review 10.  Immunoglobulin superfamily virus receptors and the evolution of adaptive immunity.

Authors:  Terence S Dermody; Eva Kirchner; Kristen M Guglielmi; Thilo Stehle
Journal:  PLoS Pathog       Date:  2009-11-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.